The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) |
93.393 |
PAR-23-155 |
Enhance Multi-agency Incident Command and Support National Operations |
19.701 |
SFOP0009656 |
OJJDP FY 2023 Second Chance Act Addressing the Needs of Incarcerated Parents and Their Minor Children |
16.831 |
O-OJJDP-2023-171713 |
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) |
93.866 |
PAR-23-163 |
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-23-154 |
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
93.847 |
PAR-23-119 |
OVC FY 2023 Child Victims and Witnesses Support Materials: Outreach and Implementation Project |
16.582 |
O-OVC-2023-171724 |
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) |
93.279 |
PAR-23-157 |
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) |
93.279 |
PAR-23-158 |
BJA FY 23 Prison Rape Elimination Act Resource Center |
16.735 |
O-BJA-2023-171723 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
93.242, 93.866 |
PAR-23-164 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) |
93.242, 93.866 |
PAR-23-165 |
FY 2023 Annual Survey of Jails in Indian Country, 2024-27 |
16.734 |
O-BJS-2023-171697 |
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) |
93.121, 93.393 |
RFA-DE-24-001 |
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-24-002 |
Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-23-028 |
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.233, 93.350, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.867 |
PAR-23-171 |
Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed) |
93.242 |
RFA-MH-23-265 |
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) |
93.394, 93.395, 93.399 |
RFA-CA-23-033 |
FY 2023 Census of Prosecutor Offices |
16.734 |
O-BJS-2023-171690 |
OVC FY 2023 National Resource Centers for Victim Research, Evaluation, and Reaching Underserved Victims |
16.582 |
O-OVC-2023-171721 |
Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed) |
93.846 |
RFA-AR-24-003 |
Improving Community Security in Syria |
19.601 |
SFOP0009647 |
Small Business Innovation Research (SBIR) Program Phase II |
11.620 |
2023-NIST-SBIR-02 |
F23AS00329 Fisheries Restoration and Irrigation Mitigation Act Fiscal Year 2023 |
15.685 |
F23AS00329 |
Building Capacity for Investigations of Racially or Ethnically Motivated Violent Extremism (REMVE) in Brazil |
19.701 |
SFOP0009508 |
OVC FY 2023 Field-Generated Solicitation: Increasing Options and Expanding Access for Victims of Crime |
16.582 |
O-OVC-2023-171714 |
OVC FY 2023 Enhanced Collaborative Model (ECM) Task Force to Combat Human Trafficking Training and Technical Assistance (TTA) Program |
16.320 |
O-OVC-2023-171709 |
OJJDP FY 2023 AMBER Alert Training and Technical Assistance Program |
16.543 |
O-OJJDP-2023-171617 |
FY 2023 Firearm Inquiry Statistics (FIST) Program, 2023-2026 |
16.734 |
O-BJS-2023-171654 |
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
93.121 |
PAR-23-162 |
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) |
93.867 |
PAR-23-141 |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional) |
93.213, 93.853, 93.855 |
RFA-NS-24-022 |
Bipartisan Infrastructure Law - Clean Energy Demonstration Program on Current and Former Mine Land Funding Opportunity Announcement |
81.255 |
DE-FOA-0003009 |
OJJDP FY 2023 Second Chance Act Youth Reentry Program |
16.812 |
O-OJJDP-2023-171707 |
Strategies for Responsibly Reporting Back Environmental Health and Non-Genomic Research Results (R01 Clinical Trial Optional) |
93.113, 93.172 |
RFA-ES-23-006 |
OVC FY 2023 Anti-Trafficking Housing Assistance Program (Services and Training and Technical Assistance) |
16.320 |
O-OVC-2023-171705 |
Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18) |
93.226 |
RFA-HS-23-012 |
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867 |
PAR-23-137 |
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) |
93.173, 93.213, 93.242, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-DC-24-001 |
Search Results 2041-2080 of 21796 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 [Next] |